Treating severe sepsis with drotrecogin alfa (activated)

被引：2

作者：

Wyncoll, D ^{[1
]}

机构：

[1] St Thomas Hosp, London SE1 7EH, England

来源：

HOSPITAL MEDICINE | 2003年 / 64卷 / 03期

关键词：

D O I：

10.12968/hosp.2003.64.3.1800

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Severe sepsis is a complex condition with mortality rates ranging from 30 to 50% in spite of advances in critical care. Xigris (drotrecogin alfa (activated)) is associated with an absolute reduction in the risk of death of 6.1% and was granted European Union marketing authorization in August 2002.

引用

收藏

页码：168 / 172

页数：5

相关论文

共 14 条

[1] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].

Angus, DC ;

Linde-Zwirble, WT ;

Lidicker, J ;

Clermont, G ;

Carcillo, J ;

Pinsky, MR .

CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310

[2]

ANGUS DC, 2002, CHEST S, V122, pS51

[3] Severe sepsis and septic shock - Definitions, epidemiology, and clinical manifestations [J].

Balk, RA .

CRITICAL CARE CLINICS, 2000, 16 (02) :179-+

[4] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].

BONE, RC ;

BALK, RA ;

CERRA, FB ;

DELLINGER, RP ;

FEIN, AM ;

KNAUS, WA ;

SCHEIN, RMH ;

SIBBALD, WJ .

CHEST, 1992, 101 (06) :1644-1655

[6]

DAVIES A, 2002, COST EFFECTIVENESS D

[7] Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life [J].

Heyland, DK ;

Hopman, W ;

Coo, H ;

Tranmer, J ;

McColl, MA .

CRITICAL CARE MEDICINE, 2000, 28 (11) :3599-3605

[8]

*INT SEPS FOR, 2001, INTENS CARE MED, V27, pS128

[9]

*LOND NEW DRUGS GR, 2002, DROTR ALF ACT GUID D

[10] Severe sepsis - A new treatment with both anticoagulant and antiinflammatory properties. [J].

Matthay, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :759-762